Rheumatology

Top Story

Pharmaceutical-grade chondroitin sulfate seen as effective in patients with knee osteoarthritis

May 25, 2017

Patients with knee osteoarthritis who took chondroitin sulfate showed improved function at 6 months compared with patients who took placebo, according to a recently published study of 603 patients.

“This compelling benefit-risk profile, in light of the known clinical risks associated with chronic usage of NSAIDs and paracetamol, underscores the potential importance of pharmaceutical-grade [chondroitin sulfate] CS in the management of knee [osteoarthritis] OA, especially in this older population requiring long-term treatment,” Jean-Yves Reginster, MD, PhD, from Liège State University in Belgium, and colleagues wrote.

In the Journals

Analysis of hospital discharges: Pulmonary embolism linked with systemic lupus erythematosus

May 25, 2017
Pulmonary embolism was associated with lupus, according to results of a recently published retrospective study. Srinadh Annangi, MBBS, from the Morehouse School…
In the Journals

Greater fiber intake linked to reduced risk for symptomatic osteoarthritis

May 25, 2017
Greater fiber intake was associated with a reduced risk for symptomatic osteoarthritis, but not radiographic osteoarthritis, according to results of a recently published…

Congressional Budget Office estimates $119 billion in savings over 10 years for House-passed AHCA

May 24, 2017
The Congressional Budget Office — a non-partisan scoring agency — and the staff of the Joint Committee on Taxation released its cost estimate for the…

ACR releases statement opposing health care cuts in Trump’s 2018 budget proposal

May 24, 2017
The American College of Rheumatology has released a statement about Trump’s 2018 budget proposal, which would cut NIH funding by $6 billion, cut FDA funding by…
More News Headlines »
Current Issues
View the Current Issue
Healio Rheumatology
Advertisement
Advertisement